Egypt inks deal with Chinese Covid vaccine maker to manufacture a billion doses per year

Posted On 3 September 2021

Number of times this article was read : 612

Egypt said Wednesday it plans to manufacture one billion doses a year of China’s Sinovac vaccine, claiming it would become the Middle East and Africa’s “biggest vaccine producer”.  Under the deal with the Chinese pharmaceutical company, a factory in Cairo will produce more than 200 million doses per year to cover “national needs”,  Health Minister Hala Zayed told a press conference. A second factory will produce three million doses per day, “or around a billion a year”, with a view to exporting the vaccine for Covid-19 and responding to demand in Africa, Zayed added.

The move would make Egypt “the biggest vaccine producer in the Middle East and Africa”, an official statement said. Heba Wali, the doctor in charge of the project, said the Egyptian drug authority had given its go-ahead and that “one million doses have already been distributed in Egypt”.

Chinese experts had previously travelled to Egypt to inspect equipment and materials for producing the Sinovac vaccine at factories belonging to state firm Vacsera. Egypt, with a population of over 100 million, has officially recorded more than 288,000 Covid-19 cases, including over 16,700 deaths. Some 7.5 million Egyptians have had at least one vaccine dose.

AFP
Other Articles in this Week's IssueMorocco: Political parties embroiled in allegations of illegal campaign spending >>
The North Africa Journal's WhatsApp Group
.

Most Recent Stories from the Region

Book: Lafarge Group and the Islamic State

Book: Lafarge Group and the Islamic State

Lafarge’s indictment for financing terrorism reveals corporate entanglements with ISIS to maintain operations in Syria. In Personne morale, Justine Augier exposes how multinationals like Lafarge navigate ethics and profit in conflict zones, raising questions on global accountability.

Written by The North Africa Journal

The North Africa Journal is a leading English-language publication focused on North Africa. The Journal covers primarily the Maghreb region and expands its general coverage to the Sahel, Egypt, and beyond, when events in those regions affect the broader North Africa geography. The Journal does not have any affiliation with any institution and has been independent since its founding in 1996. Our position is to always bring our best analysis of events affecting the region, and remain as neutral as humanly possible. Our coverage is not limited to one single topic, but ranges from economic and political affairs, to security, defense, social and environmental issues. We rely on our full staff analysts and editors to bring you best-in-class analysis. We also work with sister company MEA Risk LLC, to leverage the presence on the ground of a solid network of contributors and experts. Information on MEA Risk can be found at www.MEA-Risk.com.

Pin It on Pinterest

Share This